CASI PHARMACEUTICALS, INC. OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax
CASI PHARMACEUTICALS, INC. (CASIF) reported OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax of $37.00 thousand for the 12-month period ending 2024-12-31, per its 20-F filed 2026-05-15.
Financial Statements › Income Statement › Other Income
us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax · last filed 2026-05-15
| Period end | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax 12 month |
|---|---|
| 2024-12-31 | $37.00K 20-F · filed 2026-05-15 |